Back
Colistin: Re-emergence of the ‘forgotten’ antimicrobial agent
Oct 25, 2021

Colistin: Re-emergence of the ‘forgotten’ antimicrobial agent

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
Oct 25, 2021

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients

Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa
Oct 25, 2021

Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa

Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
Oct 25, 2021

Use of colistin in the treatment of multiple-drug-resistant gram-negative infections